Emtricitabine/Tenofovir disoproxil Mylan
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
| Name | Emtricitabine/Tenofovir disoproxil Mylan |
|---|---|
| Active Substance | emtricitabin tenofovirdizoproksilmaleat |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| ATC Code | J05AR03 |
| Medicinal product marketed in the Croatia | Nestašica |
| Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
| Link to the European Medicines Agency's (EMA) product information | download |
| Link to the European Commission's (EC) decisions | download |
| Educational materials for healthcare professionals |
Lista provjere za propisivača, verzija 2 Edukacijska brošura za propisivače PrEP indikacija, verzija 3 HIV brošura za liječenje pedijatrijskih bolesnika za propisivače, verzija 4 |
| Educational materials for patients / caregivers |
Edukacijska brošura za bolesnike, verzija 2 Kartica za korisnika lijeka, verzija 2 |
